EUCTR2016-004638-99-DK进行中（未招募）1 期
Phase II trial: uPAR PET/CT and FDG PET/CT for preoperative staging of gynecological cancers
Rigshospitalet, Department of Clinical Physiology, Nuclear Medicine and PET0 个研究点目标入组 350 人开始时间: 2017年7月4日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 350
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Female
入选标准
- •-Biopsi verified cervical, vulvar or endometrial cancer.
- •-Women refered for a suspected ovarian cancer with a RMI > 200
- •-The participants must be capable of understanding written and spoken Danish and -may have given full informed written consent
- •-age above 18
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range 50
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 300
排除标准
- •Lactation or breastfeading
- •Age above 85 years
- •Weight above 140 kg
- •Allergy Towards 68Ga-NOTA-AE105
- •Other active malignant disease within last 5 years
研究者
相似试验
进行中（未招募）
1 期
Phase II trial: uPAR PET/CT and FDG PET/MRI for determining lymph node metastases in patients with bladder cancerrinary bladder cancerMedDRA version: 19.0Level: LLTClassification code 10005004Term: Bladder cancer NOSSystem Organ Class: 100000004864EUCTR2016-001026-33-DKRigshospitalet, Department of Clinical Physiology, Nuclear Medicine and PET40
进行中（未招募）
1 期
uPAR-PET/CT for prognostication in head- and neck cancerHead and neck cancerMedDRA version: 19.0Level: HLTClassification code 10026660Term: Malignant oral cavity neoplasmsSystem Organ Class: 100000004856MedDRA version: 19.0Level: HLTClassification code 10028801Term: Oropharyngeal, nasopharyngeal and tonsillar neoplasms malignant and unspecifiedSystem Organ Class: 100000004864MedDRA version: 19.0Level: HLTClassification code 10023826Term: Laryngeal neoplasms malignantSystem Organ Class: 100000004864EUCTR2016-002082-65-DKAndreas Kjaer
进行中（未招募）
1 期
Phase II trial: PET/CT for staging advanced and localized oral and oropharyngeal cancerEUCTR2016-002360-14-DKRigshospitalet, Dapartment of of Clinical Physiology, Nuclear Medicine and PET90
进行中（未招募）
1 期
uPAR-PET - a new method for determining lymph node metastases in breast cancer patientsMedDRA version: 18.1Level: LLTClassification code 10006192Term: Breast cancer NOSSystem Organ Class: 100000004864breast cancerEUCTR2015-004503-23-DKRigshospitalet, Department of Clinical Physiology, Nucelar Medicine and PET
进行中（未招募）
1 期
uPAR-PET/MRI in patients with prostate cancer for evaluation of tumor aggressivenessProstate cancerEUCTR2017-002276-37-DKRigshospitalet, Department of Clinical Physiology, Nuclear Medicine & PET52